Background: Tuberous sclerosis complex (TSC ... harboring a novel pathogenic variant in the TSC2 gene. Cardiovascular characteristics included a history of heart valve disease, a bicuspid aortic valve ...

Genetic testing confirmed the diagnosis of tuberous sclerosis complex, identifying a mutation in the TSC2 gene. The entire family was evaluated for inherited disorders, leading to the detection of ...

The market is fueled by the increasing application of genetic therapies, wherein novel approaches in the form of genetic material manipulation may provide a route for correction or compensation of the ...

These skin findings, together with pulmonary lymphangioleiomyomatosis, pointed to the diagnosis of tuberous sclerosis complex (TSC). TSC is a genetic disorder characterized by the presence of ...

Abstract and Introduction Clinical Features of Tuberous Sclerosis Complex Genetics of Tuberous Sclerosis Diagnosis of Tuberous Sclerosis Complex by DNA Analysis References Hypomelanotic macules ...

Multiple sclerosis (MS) is a chronic (long-term) condition with symptoms that vary from person to person. With proper management of symptoms, people living with MS can often remain active for many ...

Multiple sclerosis (MS) causes neurological symptoms that typically worsen over time. People with MS typically experience relapses, during which symptoms worsen or new symptoms appear. Depending ...

Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva's ...

today announced the discovery of new immune biomarkers in patients with non-active secondary progressive multiple sclerosis (na-SPMS) treated with nasal foralumab. We believe these findings ...